U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ALPROLIX
  1. Approved Blood Products

STN: 125444
Proper Name: Coagulation Factor IX (Recombinant), Fc Fusion Protein
Tradename: ALPROLIX
Manufacturer: Bioverativ Therapeutics, Inc.
Indication:

  • Perioperative management of surgical prophylaxis; Routine prophylaxis to prevent or reduce the frequency of bleeding episodes; Control and prevention of bleeding episodes.

Product Information

Supporting Documents

Back to Top